Injective Tests Key Support Level Amid Market Volatility
Injective's price action shows a critical battle at the $6.41 support level after a recent breakout.
Injective's price action shows a critical battle at the $6.41 support level after a recent breakout. Injective (INJ) is trading at ₹668 ($7.03), down 1.7% since this brief published. This is an original Token Times brief based on reporting by AMBCrypto, with live market data added, as of Sun, 01 Nov 2026 19:30:01 UTC.
The outcome of this support test could determine whether Injective sustains its bullish momentum or faces a deeper correction, impacting investor sentiment and trading strategies.
- Injective broke out from a cup and handle pattern, targeting $18 if $6 holds.
- Current price action shows sellers pressuring the $6.41 support level.
- Market cap remains above $700M despite recent price decline.
- XRP Tests Key Support Level After Breaking Downward from Ascending Channel
- XRP Tests Historical Support Level Amid Market Recovery
- Injective Tests Key Support Level Amid Market Volatility — this brief
Injective (INJ) is currently facing a critical test at the $6.41 support level after breaking out from a cup and handle pattern, according to AMBCrypto.
The breakout suggests a potential rally to $18 if the $6 support level holds. However, recent price action indicates that sellers are gaining momentum, putting pressure on this key support level.
Despite the current downward pressure, Injective's market cap remains robust at $715.27M, reflecting the coin's resilience in the broader market context.
The overall crypto market remains relatively flat, with 
Bitcoin showing a modest 24-hour gain of 0.41%. The Fear & Greed index stands at 34, indicating a market sentiment of fear.
If Injective can successfully defend the $6.41 support, it could regain bullish momentum and potentially target higher price levels. Conversely, a breakdown below this level could lead to further downside.
Since this brief published about 1 hour ago, Injective (INJ) has moved from ₹679.61$7.15 to ₹668.20$7.03 — -1.68%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹745.81 (about $7.03), down 3.6% over 24 hours. The rupee itself trades about 11.6% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Injective Tests Key Support Level Amid Market Volatility — questions & answers
What is the significance of the $6.41 support level for Injective?
The $6.41 level is crucial as it represents the breakout area from the cup and handle pattern. Holding this level is key for sustaining the bullish trend.
What is the potential price target if Injective maintains its bullish momentum?
If the $6 support holds, analysts predict a potential rally to $18.
How has the broader market affected Injective's price?
The overall flat market and Bitcoin's modest gain suggest limited external influence on Injective's price action, which is primarily driven by its own technical factors.
How much is 1 Injective worth in rupee today?
About ₹745.81 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $7.03. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 1.68% since this brief first published — trading at ₹668 ($7.03) now versus ₹680 ($7.15) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from AMBCrypto. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.